Publication details

Zhodnocení bezpečnosti a tolerability dimethyl fumarátu a fingolimodu v léčbě roztroušené sklerózy

Title in English Evaluation of safety and tolerability dimethyl fumarate and fingolimod for the treatment of multiple sclerosis
Authors

ŠTOURAČ Pavel

Year of publication 2017
Type Popularization text
MU Faculty or unit

Faculty of Medicine

Citation
Description Dimethyl fumarate and fingolimod are effective drugs for the treatment of relapsing-remitting multiple sclerosis. Comparing safety and tolerability of both drugs we conclude that dimethyl fumarate requires less extensive safety monitoring and šidě effects are temporarily and treatable. Fingolimod requires more extensive safety monitoring during treatment. Risk of a progressive multifocal leukoencephalopathy is very low for both drugs.

You are running an old browser version. We recommend updating your browser to its latest version.

More info